Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes

R Van Haren1, D Feldman, A A Sinha

  • 1Division of Dermatology and Cutaneous Sciences, Center for Investigative Dermatology, 4179 Biomedical and Physical Sciences Building, College of Human Medicine, Michigan State University, East Lansing, MI 48823, USA.

Abstract

Insights

This study compared gene expression data from 10 nonmelanoma skin cancer studies. Overlapping differentially expressed genes (DEGs) and pathways were identified, highlighting potential therapeutic targets and the need for consistent experimental methods.

Area of Science:

  • Genomics
  • Oncology
  • Biotechnology

Background:

  • DNA microarray technology identifies gene expression alterations in human cancers.
  • Validating and understanding the biological significance of these gene expression changes is challenging.
  • Microarray analysis is increasingly used to study nonmelanoma skin cancers like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

Purpose of the Study:

  • To rigorously compare experimental data from multiple microarray studies on BCC and SCC.
  • To identify consensus differentially expressed genes (DEGs) relevant to BCC and SCC pathogenesis.
  • To evaluate factors influencing consensus among DEGs, such as experimental and statistical parameters.

Main Methods:

  • Systematic comparison of 10 studies utilizing DNA microarray technology for BCC/SCC research.
  • Analysis of 1133 reported DEGs across studies to identify overlaps.
  • Documentation of variations in experimental methods (sample type, tissue handling, microarray chips, statistical analysis).

Main Results:

  • Identified 64 DEG overlaps across studies: 18 in SCC vs. SCC, 18 in BCC vs. BCC, and 28 in BCC vs. SCC comparisons.
  • Observed significant differences in experimental methods potentially explaining the lack of consensus.
  • Enzymatic and structural/adhesion genes were the most dysregulated pathways across studies.

Conclusions:

  • Overlapping DEGs and highly represented biological pathways are crucial for understanding BCC/SCC pathogenesis and may offer therapeutic targets.
  • Standardizing experimental methods across research laboratories is essential to improve DEG validity and strengthen conclusions from microarray data.

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...